Myositis is a general term meaning inflammation in the muscles. More specific types of myositis include dermatomyositis, immune-mediated necrotizing myositis, overlap myositis, polymyositis, and inclusion body myositis. These are systemic diseases, which may affect several areas of the body, and some forms of myositis such as amyopathic dermatomyositis can primarily affect the skin (rashes) and lungs (interstitial lung disease) with minimal effects on the muscle tissue. Many of these diseases are autoimmune in nature, meaning that the immune system attacks the tissues involved, causing inflammation.
There are many autoantibodies such as Jo-1, SRP, MDA5, and others which are markers in the blood that classify different types of myositis. Early recognition and aggressive, comprehensive care are critical to control these diseases and prevent complications.
The UCLA Myositis Program is a comprehensive, multidisciplinary team of experts dedicated to providing tailored, individualized care for patients with myositis. This team includes rheumatologists with experience in diagnosing and treating patients with these rare diseases, as well as experts in neurology, muscle pathology, pulmonology, dermatology, and cardiology. The goals of the UCLA Myositis Program are to provide the highest level of individualized, tailored care to patients with myositis. Patients with suspected or diagnosed myositis, their families, and doctors can all benefit from our program, which includes care by a team of experts in these rare but serious and potentially life-threatening diseases.
Please note, the UCLA Myositis Program only evaluates adult patients (those 18 years and older). For pediatric patients, please visit UCLA Pediatric Rheumatology.